A major advance in cancer research is emerging with the use of nanobodies to reactivate mutated p53. This crucial tumor protector protein is frequently inactivated in various kinds of malignancies, leading uncontrolled https://fellowfavorite.com/story23362017/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-malignant-treatment